Search Results - "Tabacof, J."

Treatment outcomes for Hodgkin's lymphoma patients aged 60 and older: A report from the Brazilian prospective Hodgkin's lymphoma registry by Biasoli, I., Delamain, M., Simoes, B.P., Castro, N., Gaiolla, R., Solza, C., Silveira, T., Praxedes, M., Farley, J., Boquimpani, C., Sola, C.B., Clementino, N., Perini, G.F., Franceschi, F., Chiattone, C.S., Baioccchi, O., Pagnano, K., Tabacof, J., Steffenello, G., Soares, A., Milito, C., Souza, C., Luminari, S., Morais, J., Spector, N.

Get full text

Treatment outcomes for Hodgkin's lymphoma patients aged 60 and older: A report from the Brazilian prospective H odgkin's lymphoma registry by Biasoli, I., Delamain, M., Simoes, B.P., Castro, N., Gaiolla, R., Solza, C., Silveira, T., Praxedes, M., Farley, J., Boquimpani, C., Sola, C.B., Clementino, N., Perini, G.F., Franceschi, F., Chiattone, C.S., Baioccchi, O., Pagnano, K., Tabacof, J., Steffenello, G., Soares, A., Milito, C., Souza, C., Luminari, S., Morais, J., Spector, N.

Get full text

Pretreatment level of CA 19–9 is a prognostic factor in advanced pancreatic cancer treated with chemotherapy by Gansl, R. C., Reis, P. T., Tabacof, J., Simon, S. D., Machado, M. C., Borghesi, G., Saad, E. D.

“…Abstract only…”
Get full text

PSA decline does not correlate with overall survival in clinical trials with docetaxel for androgen independent prostate cancer (AIPC) by Smaletz, O., Moreira, F. R., Simon, S. D., Katz, A., Gansl, R. C., Tabacof, J.

“…Abstract only…”
Get full text

Imatinib (STI 571) is active in patients (PTS) with high-grade gliomas progressing on standard therapy by Katz, A., Barrios, C. H., Abramoff, R., Simon, S. D., Tabacof, J., Gansl, R. C.

“…Abstract only…”
Get full text

Imatinib (STI 571) is active in patients (PTS) with high-grade gliomas progressing on standard therapy by Katz, A., Barrios, C. H., Abramoff, R., Simon, S. D., Tabacof, J., Gansl, R. C.

“…Abstract only…”
Get full text

41 Gefitinib for patients with advanced NSCLC treated on the expanded access programme: A institution experience by Cruz, M., Katz, A., Simon, S., Tabacof, J., Gansl, R., Smaletz, O.

Get full text

Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine by Saad, Everardo D, Machado, Marcel C, Wajsbrot, Dalia, Abramoff, Roberto, Hoff, Paulo M, Tabacof, Jacques, Katz, Artur, Simon, Sergio D, Gansl, René C

“…Serum levels of CA 19-9 correlate with survival among patients with pancreatic cancer treated with surgery or radiation therapy. In addition, CA 19-9 responses…”
Get more information

Strongyloides hyperinfection in two patients with lymphoma, purulent meningitis, and sepsis by Tabacof, J, Feher, O, Katz, A, Simon, S D, Gansl, R C

“…Strongyloides stercoralis hyperinfection syndrome is a rare complication of strongyloidiasis that occurs in immunosuppressed patients. It is caused by…”
Get more information